Dr. Mitchell Shiffman is one of the world’s most recognized research physicians in the development of new treatments for viral hepatitis B, C and many other forms of liver disease. Dr. Shiffman is a regular consultant to many pharmaceutical companies and has a vast experience conducting clinical trials in patients with liver disease. This experience allows the Liver Institute of Virginia medical staff the ability to offer new and more effective treatments to patients with viral hepatitis B and C, fatty liver disease and other forms of liver disorders.
The Liver Institute of Virginia helps to develop new medications for various liver disorders by participating in clinical trials with various pharmaceutical companies. Clinical trials offer patients with chronic liver disorders the opportunity to receive new and potentially highly effective medications that are not currently available by prescription.
The Liver Institute of Virginia is currently conducting 12 clinical trials studying Chronic Hepatitis C (HCV), Hepatitis B Virus, and Non Alcoholic Steatohepatitis (NASH). If you think you may be eligible for one of these clinical trials speak with your physician or call the Liver Institute of Virginia at (757) 947-3190.